The European Innovation Council awards €1.8 million to Vésale Bioscience’s PhageDiag project

Namur (Belgium), 13 January 2023

Vésale Bioscience is developing innovative precision phage therapy solutions to treat bacterial infections resistant to antibiotics, and today announces that it has received a €1.8 million grant from the European Innovation Council to accelerate the development of its diagnostic tool enabling personalized phage therapies.

More info via, Spokesman – Corporate & Strategy Communication Director.

1920 1280 Vesale Bioscience